Authors: Par, A Telegdy, L Dalmi, L Muller, E

Citation: A. Par et al., Therapy for chronic hepatitis C, J PHYSL-PAR, 95(1-6), 2001, pp. 399-405

Authors: Biro, L Varga, L Par, A Nemesanszky, E Csepregi, A Telegdy, L Ibranyi, E David, K Horvath, G Szentgyorgyi, L Nagy, I Dalmi, L Abonyi, M Fust, G Horanyi, M

Citation: L. Biro et al., Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b, IMMUNOL LET, 72(2), 2000, pp. 69-74

Authors: Biro, L Varga, L Par, A Nemesanszky, E Telegdy, L Ibranyi, E David, K Horvath, G Szentgyorgyi, L Nagy, I Dalmi, L Abonyi, M Fust, G Horanyi, M Csepregi, A

Citation: L. Biro et al., C5b-9 and interleukin-6 in chronic hepatitis C - Surrogate markers predicting short-term response to interferon alpha-2b, SC J GASTR, 35(10), 2000, pp. 1092-1096